(Q35096835)

6 August 2017

1 reference

title

Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy (English)

1 reference

6 August 2017

0 references

0 references

1 reference

1 reference

William H Maisel

1

1 reference

6 August 2017

Lynne Warner Stevenson

series ordinal

2

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

American Journal of Cardiology

6 August 2017

published in

1 reference

6 August 2017

volume

91

1 reference

6 August 2017

issue

6A

1 reference

6 August 2017

page(s)

2D-8D

1 reference

Medical management of advanced heart failure

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Improving outcomes in heart failure: It's not unusual beyond usual care.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Impact of atrial fibrillation on the risk of death: the Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

The epidemiology of heart failure: the Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials. Studies of Left V

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Dofetilide in patients with congestive heart failure and left ventricular dysfunction. Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Prognosis of congestive heart failure after prior myocardial infarction in older persons with atrial fibrillation versus sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Atrial fibrillation in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Incidence, predictive factors, and prognostic significance of supraventricular tachyarrhythmias in congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Ionic determinants of atrial fibrillation and Ca2+ channel abnormalities : cause, consequence, or innocent bystander?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

The effect of atrial dilatation on the genesis of atrial arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Electrophysiological remodeling in hypertrophy and heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Effects of experimental heart failure on atrial cellular and ionic electrophysiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

The hemodynamic consequences of cardiac arrhythmias: evaluation of the relative roles of abnormal atrioventricular sequencing, irregularity of ventricular rhythm and atrial fibrillation in a canine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Tachycardia-induced cardiomyopathy: a review of animal models and clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Hemodynamic effects of an irregular sequence of ventricular cycle lengths during atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Tachycardiomyopathy: mechanisms and clinical implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Severe cardiomyopathy due to chronic rapidly conducted atrial fibrillation: complete recovery after restoration of sinus rhythm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Atrial fibrillation and congestive heart failure: specific considerations at the intersection of two common and important cardiac disease sets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Efficacy of dofetilide in the treatment of atrial fibrillation-flutter in patients with reduced left ventricular function: a Danish investigations of arrhythmia and mortality on dofetilide (diamond) substudy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Diagnosis and treatment of heart failure based on left ventricular systolic or diastolic dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

A comparison of rate control and rhythm control in patients with atrial fibrillation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

Atrial fibrillation and congestive heart failure: the intersection of two common diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2903373-8

10.1016/S0002-9149(02)03373-8

7 January 2021

Identifiers

DOI

1 reference

6 August 2017

1 reference